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Measurement of the oxidation state of
mitochondrial cytochrome c from the neocortex
of the mammalian brain
Y. Sakata, M. Abajian, M. O. Ripple, and R. Springett*
Department of Radiology, The Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA
*RSpringett@Dartmouth.edu

Abstract: Diffuse optical remission spectra from the mammalian neocortex
at visible wavelengths contain spectral features originating from the
mitochondria. A new algorithm is presented, based on analytically relating
the first differential of the attenuation spectrum to the first differential of the
chromophore spectra, that can separate and calculate the oxidation state of
cytochrome c as well as the absolute concentration and saturation of
hemoglobin. The algorithm is validated in phantoms and then tested on the
neocortex of the rat during an anoxic challenge. Implementation of the
algorithm will provide detailed information of mitochondrial oxygenation
and mitochondrial function in physiological studies of the mammalian
brain.
© 2012 Optical Society of America
OCIS codes: (170.0170) Medical optics and biotechnology; (170.1470) Blood or tissue
constituent monitoring.
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1. Introduction
The optical attenuation spectrum of the mammalian brain is dominated by the absorption of
hemoglobin at visible wavelengths and the mitochondrial cytochromes, which are heme
containing proteins of the electron transport chain, only make a minor contribution. The
absorption band of the hemes change depending on whether the heme is reduced (carrying an
electron) or oxidized (not carrying an electron) and this property has been used repeatedly to
probe function of the isolated enzymes [1–3] and mitochondrial preparations [4–6] using twowavelength difference spectrophotometry, and we have developed a full-spectral system to
calculate the oxidation changes of all the mitochondrial hemes from cells in suspension [7]. In
the late 1970s and early 1980s, the two-wavelength technique was used to measure oxidation
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changes of cytochrome oxidase from the exposed mammalian cortex [8–10] but there was
considerable skepticism that this method could accurately separate the cytochrome signal
from the much greater hemoglobin signals and this technique has not been pursued into the
present day. Few attempts have been made to measure the cytochromes with modern multiwavelength visible spectroscopy systems probably because of their controversial history,
problems with crosstalk and the difficulty in validating the signal. Where they have been
measured [11,12], they have not been quantified [11] or interpreted [11,12]. Improvements in
spectroscopic detection and our understanding of the light transport through tissue now
warrant a reexamination of the problem as these mitochondrial signals are sensitive to both
mitochondrial function and mitochondrial oxygenation and thus have the potential to provide
valuable physiological information on the energy metabolism of the brain.
Current optical imaging systems either image the brain illuminated with several
wavelengths of monochromatic light [13,14] or use a spectrograph with a CCD detector to
measure full spectra along a line across the cortex [15–17]. Each of these techniques only
measure changes in hemoglobin concentration from the change in attenuation spectrum by
applying a modified Beer-Lambert law. They all require a model to calculate the differential
pathlength, which must be based on estimations of the underlying hemoglobin concentration
and saturation as well as tissue scattering coefficient. Furthermore, the wavelength
dependence of the differential pathlength distorts the attenuation spectrum compared to the
chromophore extinction spectra leading to crosstalk between the hemoglobin signals [18].
This has led to controversy with regard to the “initial dip” in functional activation studies [19–
23], the presence or absence of which depends on small changes in deoxyhemoglobin (Hb) in
the presence of large changes in oxyhemoglobin (HbO2). A recent innovation is laminar
optical tomography (LOT) [24] in which the image of a laser spot and the image of multiple
detector fibers is scanned across the cortex with mirrors mounted on galvanometers. The
detector fibers are mounted at differing separations from the laser spot so that they sample
different depths into the tissue and it is possible to reconstruct a 3-dimensional image of the
cortex. However, even this technique uses an estimate of the baseline hemoglobin
concentration to reconstruct tomographic images of hemoglobin concentration.
The mitochondrial electron transport chain contains 7 hemes embedded in 4 proteins:
complex II contains b560, the bc1 complex contains bL, bH and c1 (hence its name), Cytc
contains a c-type heme and CytOx contains heme a and a3. The hemes are classed as either a,
b or c-type depending on modifications to the porphyrin ring [25] and the modification,
combined with the protein environment, confers each of the 7 heme centers a distinct
absorption spectrum. Typically, the reduced heme has a strong and sharp absorption band
whereas the oxidized heme has a broader and weaker absorption spectrum.
The mitochondrial cytochromes are present in the brain at much lower concentrations than
hemoglobin and the absorption spectrum of the hemes is weaker than hemoglobin in part
because each molecule of hemoglobin contains four hemes. Together, this makes the
cytochrome signals highly susceptible to crosstalk from the hemoglobin. The cytochromes
with the highest concentration in the brain, and so most amenable to separation from the
hemoglobin signals, are cytochrome c (Cytc) and cytochrome oxidase (CytOx). Cytc is a
12.5KDa protein with an absorption band at 550nm which diffuses in the intermembrane
space and transfers electrons from the bc1 complex to CytOx. CytOx contains four redox
centers. The CuA center is the electron acceptor from Cytc. From there, electrons are passed to
the heme a center and then to the binuclear center consisting of heme a3 and CuB where
oxygen is reduced to water. Oxidized CuA has an absorption band at 830nm and the oxidation
changes have been measured with near infrared spectroscopy [26,27]. Cytc and CuA have
similar midpoint potentials, are on the same side of the inner mitochondrial membrane and are
expected to be in redox equilibrium and so provide essentially the same information. Both the
heme a and heme a3 centers have absorption bands at 605nm which cannot be resolved
spectroscopically. However the mixed signal, often referred to as Cytaa3, is dominated by the
heme a center as it has the stronger absorption band [28].
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The goal of this paper is to introduce and validate a new algorithm based on the first
differential of the attenuation spectrum combined with a Monte Carlo simulation of the light
transport through tissue to calculate the concentration of reduced Cytc, as well as the absolute
hemoglobin concentration and saturation, from the attenuation spectrum from the exposed
cerebral cortex of small animals. To this end, studies were performed in phantoms where the
concentration of Hb, HbO2 and reduced Cytc could be varied independently and, for the first
time, from the cerebral cortex of rats during a brief anoxic challenge.
2. Methods
2.1. Instrumentation
An optode probe was developed that could be placed against the thinned skull of a rat that
consisted of two 400μm fibers with a numerical aperture of 0.37 separated by 1mm housed in
a 6.35mm diameter black-acetal rod. The probe was also used for the phantom studies. The
source optode was coupled to a stabilized tungsten halogen lamp filtered with a KG2 heat
absorbing filter to remove the infrared and a BG38 colored glass filter to shape the incident
light spectrum to match the hemoglobin absorption spectrum. Output power at the sample was
≈160μW. Light from the detector fiber was F#-matched onto the slits of an F4.0, 0.3m
spectrograph (Triax 320, JY Horiba, Edison, NJ,) equipped with a 600g/mm grating blazed at
500nm. Complete spectra between 508 and 640nm were collected on a 1024 × 128 pixel
back-thinned CCD (charge coupled device) detector with 26 × 26μm pixels cooled to 210
Kelvin (DV401BV, Andor Technology, Hartford, CT). The spectrograph was wavelength
calibrated daily against the green and yellow-doublet mercury lines. The pixel bandpass was
≈0.13nm and the slits set to 200μm to give a spectral resolution of ≈1nm. Spectra were
intensity calibrated against a polytetrafluoroethylene (PTFE or Teflon®) phantom. Spectra
were collected contiguously at 50Hz and every 25 attenuation spectra were averaged to give a
temporal resolution of 0.5seconds.
2.2. Algorithms
The attenuation, A, of light through tissue is defined as

A ( λ ) = − Ln ( I D ( λ ) I S ( λ ) )

(1)

where λ is wavelength, I D ( λ ) is the detected light intensity, and I S ( λ ) is the source light
intensity. Assuming a given anisotropy factor, the attenuation can be modeled as a function of
tissue absorption coefficient ( µ a ) and reduced scattering coefficient ( µ s ) which are both
dependent on wavelength. The absorption is the sum of the absorption from the tissue
chromophores weighted by their concentration, e.g.,

µ a ( λ ) = ∑ Ck ε k ( λ )

(2)

k

where Ck is the concentration of the kth chromophore, ε k ( λ ) is the specific absorption
spectrum of the kth chromophore in natural log units and the sum is over all the
chromophores. Most present day spectroscopy systems measure the change in the attenuation
and relate it to the change in chromophore concentration and change in scattering through:

∂A
∂A
∆A =
∆µ a +
∆µ s =ρ∆µ a + σ∆µ s
∂µ a
∂µ s

(3)

where ρ has units of length and is called the differential pathlength by analogy with the BeerLambert law and σ has units of length and is referred to here as the differential scatterlength
as it has units of length and is the scattering equivalent of the differential pathlength. Both
terms are wavelength dependent. Usually it is assumed that the scattering coefficient does not
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change so that ∆µ s is zero and then the change in attenuation is related to the change in
chromophore concentrations by

∆A ( λ=
) ρ ( λ ) ∑ ∆Ck ε k ( λ )

(4)

k

This is the formal derivation of the modified Beer-Lambert law. The change in chromophore
concentration can be calculated from the change in attenuation spectrum measured at multiple
wavelengths using a classical least-squares algorithm if the chromophore extinction spectra
are known.
Attempts to measure the absolute concentration of hemoglobin directly from the
attenuation spectrum using a Monte Carlo simulation to model the relationship between
attenuation and absorption coefficient have been largely unsuccessful [18]. The relationship
between attenuation and chromophore concentration is highly non-linear and dependent on
boundary conditions. We have taken a different approach to calculating absolute chromophore
concentrations from the attenuation spectra. If the attenuation spectrum is differentiated with
respect to wavelength then, because attenuation is a function of µ a and µ s , the first
differential is given by

dA ( λ )
∂A d µ a ∂A d µ s
′(λ )
= A=
+
dλ
∂µ a d λ ∂µ s d λ

(5)

The first term on the right is just the product of the differential pathlength and the first
differential of the specific extinction chromophores weighted by their concentration, whereas
the second term is the product of the differential scatterlength and the first differential of the
scattering coefficient with respect to wavelength. Thus Eq. (5) reduces to

=
A′ ( λ ) ρ ( λ ) ∑ Ck ε k′ ( λ ) + σ ( λ ) ε s′ ( λ )

(6)

k

where ε k′ (λ ) is the first differential of the specific extinction coefficient of the kth
chromophore with respect to wavelength and ε s′ (λ ) is the first differential of the scattering
coefficient with respect to wavelength. We refer to the first and second term on the right of
Eq. (6) as the absorption and scattering term but both terms have dependence on both
absorption and scattering coefficient through the differential pathlength and differential
scatterlength, respectively.

Fig. 1. Specific extinction spectra (upper) and 1st differential of the specific extinction spectra
(lower) of HbO2 and Hb (left) and Cytc and Cytaa3 (right).
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One advantage of using the first differential instead of the attenuation spectrum is that it
makes the measurement, A′ ( λ ) , approximately linear with respect to the absolute
chromophore concentrations (see Eq. (6)). In addition, measurement of the scattering
coefficient of tissue has been shown to be slowly varying function of wavelength compared to
the chromophores [29] so that the scattering term of Eq. (6) is small compared to the
absorption term. Finally, the first differential spectrum has preferential sensitivity to the
cytochromes over the hemoglobin because the absorption spectra of the former are sharper
than the latter. This is illustrated in Fig. 1 which compares the specific extinction spectra of
HbO2, Hb, Cytc and Cytaa3 and the first differential of the specific extinction spectra. The
magnitude of the specific extinction spectra of Cytc and Cytaa3 is approximately half the
magnitude of the specific extinction spectra of HbO2 and Hb whereas the magnitude of the
first differential of the extinction spectra of Cytc and Cytaa3 are approximately equal to that of
HbO2 and twice that of Hb.
2.3. Monte Carlo simulations
A Monte Carlo simulation of light transport through tissue was implemented in Delphi 2010
(Embarcadero, CA) as a Win32 application. The model follows multiple photons launched
from the source fiber into a semi-infinite medium assuming zero absorption, a given
anisotropy factor and a given full scattering coefficient. It generates a histogram, Η ( x, µ s ) ,
that represents the fraction of launched photons that were detected as a function of distance, x,
that the photon traveled in the medium before being detected and for a given scattering
coefficient. The scattering angle was calculated using the Henyey-Greenstein scattering
function [30] and the anisotropy factor was set to 0.9 for all simulations. The model uses the
radial symmetry to decrease the computational time. Photons are launched with equal
probability over the area and acceptance cone of the source fiber and only photons which exit
the medium within the acceptance cone of the detector fiber and in an annulus between the
inter optode spacing plus and minus the detector fiber radius are detected. The detected
photons are then weighted by the fraction of the circumference at the exit radius that falls
within the detector fiber. The source and detector fiber acceptance cones are corrected for the
refractive index of tissue (1.3). The code is multi-threaded to make full use of multi-core
processors. The photons are followed until they exit the medium or for a maximum of 500mm
at which point they would be extinguished by the absorption. It was found that the parameter
most sensitive to the maximum pathlength was the differential pathlength when the absorption
coefficient was zero. The value of 500mm was chosen because this value had negligible
impact on this parameter.
For each simulation, 108 photons were launched and, depending on scattering coefficient,
between 1.6 and 6.1 × 105 were detected based on statistics of between 0.3 and 1.2 × 106
photons that exited within the detection annulus.
Once the histogram has been generated for each scattering coefficient, the intensity of the
detected light, I D , can then be calculated for any given absorption coefficient of the tissue by
∞

I=
I S ∫ Η ( x, µ s )e − ua x dx
D

(7)

0

where I S is the number of photons launched per second (source light intensity), x is the
distance that the photons have traveled. The exponential factor gives the fraction of photons
which are not absorbed by the medium. Using Eqs. (1) and (7), and the definition of the
differential pathlength given in Eq. (3), the differential pathlength can be calculated from

 1 ∞
=
ρ   ∫ Η ( x, µ s ) xe − ua x dx
 ID  0
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Equation (8) confirms that the differential pathlength is equal to the mean distance traveled
[31] but there is no simple physical interpretation for the differential scatterlength. Using Eqs.
(1) and (7), and the definition of the differential pathlength given in Eq. (3), the differential
scatterlength can be calculated from

 1  ∞ ∂Η ( x, µ s ) − ua x
e dx
∫
∂µ s
 ID  0

σ = −

(9)

and the differential of the histogram can be calculated numerically from the difference
between two histograms with slightly different scattering coefficients.
Whereas generating the histogram is computationally time consuming, Eqs. (7), (8) and
(9) can be applied to rapidly calculate the attenuation, differential pathlength and differential
scattering spectrum for a given absorption spectrum. The absorption coefficient is calculated
at a particular wavelength from the chromophore concentrations using Eq. (2).
2.4. Spectral fitting
To calculate the concentration of Hb, HbO2 and Cytc, we first estimate the concentrations of
each chromophore and use Eq. (2) to calculate µ a and then Eq. (8) to calculate differential
pathlength at every wavelength. We perform a least squares linear fit of the first differential of
the attenuation spectrum to Eq. (6) to calculate the next iteration of the chromophore
concentrations. The scatterlength has a very weak wavelength-dependence and this term can
be fitted as an offset. In practice, the chromophore spectra are so orthogonal and the
differential pathlength such a weak function of the absorption coefficient that this process
converges very rapidly from any estimation of chromophore concentration. Total hemoglobin
(HbT) is defined as the sum of HbO2 and Hb and hemoglobin saturation (SO2) is calculated
from the ratio HbO2 to HbT.
2.5. In vitro studies
Liquid phantoms were made from a mixture of fresh rat blood, intralipid and cytochrome c in
physiological saline buffered by 20mM HEPES at pH 7.4. Fresh rat blood was obtained from
the tail vein of Wistar rats and the hemoglobin content was measured with a co-oximeter
(Rapidlab 845, Bayer Corporation Diagnostics Division, Norwood, MA) and converted to a
concentration in units of μmoles/L assuming an atomic weight of hemoglobin to be
64,500g/mole. All blood samples had a combined met-hemoglobin and carbon monoxyhemoglobin content of less than 2%. Bovine Cytc was obtained from Sigma and used without
further purification. Stock solutions of Cytc were reduced with a small quantity of sodium
ascorbate and the concentration of Cytc was calculated from the absorption spectrum
measured with a spectrophotometer using the same specific absorption spectrum as used in
the subsequent studies.
The phantom was measured in a 6mL cylindrical chamber of inside diameter 17mm
maintained at 37°C by a water jacket. The phantom was stirred with a glass stir bar and
oxygen tension within the chamber was measured from the fluorescence lifetime of a
phosphorescent membrane (Tautheta Instruments, Boulder, CO) located at the bottom of the
chamber. The phantom was reversibly oxygenated or deoxygenated under computer control
by exchange of oxygen across 90mm of silicone tubing (Renasil, Braintree Scientific,
Braintree, MA) immersed in the cell suspension. Deoxygenation was aided by the addition of
a small quantity of yeast to the phantom.
2.6. In vivo studies
All animal studies were carried out with approval of the local Institutional Animal Care and
Use Committee. Wistar rats were anesthetized with 2% isoflurane, a tracheotomy performed
and the animals mechanically ventilated. A catheter was sited in the femoral artery for
collection of blood samples for blood gas analysis and for continuous monitoring of blood
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pressure and heart rate. A second catheter was sited in the femoral vein for infusion of drugs
where required. The fur over the head was shaved and the scalp removed. The skull over the
parietal cortex was then thinned to translucency with a burr and the bone sealed with
cyanoacrylate glue. Rectal temperature was monitored continuously and the animals
maintained at 37°C using a heated water mattress. End-tidal CO2 was monitored continuously
with a capnogram and maintained so that arterial CO2 tension was in the range 35-40mmHg.
Arterial saturation was monitored continuously with a pulse oximeter. A computerized gas
blender was used to mix the inspired gases and baseline inspired oxygen fraction (FiO2) was
set to 0.30 with the balance nitrogen. At the end of surgery, the isoflurane was decreased to
1.5% and the animals were allowed to stabilize for one hour before commencement of the
study. Results are expressed as mean ± SD (n = 6).
3. Results
3.1. Simulations
Figure 2 compares the spectrum of the reduced scattering coefficient of 1% intralipid [32], the
absorption spectrum of hemoglobin at a concentration of 60µmoles/L and a saturation of 75%,
and the absorption spectrum of 10µmoles/L of reduced Cytc in the wavelength range 510640nm. The 1% intralipid models the scattering coefficient of the brain and the hemoglobin
and Cytc values approximate those found in the rat brain. The absorption spectrum is
dominated by hemoglobin and the absorption of hemoglobin is almost one order of magnitude
greater than the absorption of Cytc. Figure 2 also illustrates that the absorption spectra are
more feature rich than the scattering spectrum.

Fig. 2. Wavelength dependence of the scattering coefficient, absorption coefficients of
60μmoles/L hemoglobin (H) at a saturation of 75% with (H & Cytc) and without (H only)
10µmoles/L of Cytc, and absorption coefficient of 10μmoles/L of Cytc.

The attenuation spectra, differential pathlength and differential scatterlength calculated
with the Monte Carlo simulation using the optical properties shown in Fig. 2, are shown in
Fig. 3. The scatterlength is negative, e.g. an increase in scattering coefficient creates a
decrease in attenuation, and the scatter length is shown scaled by a factor of −1 for reasons of
clarity. The absolute attenuation depends strongly on the exact numerical aperture and the
coupling efficiency of the fibers, the latter can change between sample and reference. This
results in an offset between the measured and modeled attenuation spectrum which
complicates spectral fitting directly to the attenuation spectrum. This offset is removed by
taking the first differential. The mean pathlength between 520 and 580nm is ≈2.16mm and
varies by +12% at 520nm and –5% at 544nm. The differential pathlength increases
substantially at longer wavelengths where the absorption due to hemoglobin is lower. The
penetration of the light into the tissue is also expected to be deeper over this wavelength
range.
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Fig. 3. Wavelength dependence and scattering dependence of attenuation, differential
pathlength and differential scatterlength calculated from Monte Carlo simulations. Left Panels:
Wavelength dependence of the attenuation (upper), differential pathlength and scatterlength
(lower) for a media with the optical properties shown in Fig. 2. The differential scatterlength is
scaled by a factor of −1 for clarity. Right panels: scattering dependence of attenuation (upper)
and differential pathlength (lower) for a medium with absorption coefficients of 0.60 and
0.05mm−1.

The variation of attenuation and differential pathlength with reduced scattering coefficient
for absorption coefficients of 0.60 and 0.05mm−1 is shown in the right panels of Fig. 3. An
absorption coefficient of 0.6mm−1 is representative of the absorption spectrum between 520
and 580nm whereas an absorption coefficient of 0.05mm−1 corresponds to a wavelength of
≈610nm close to the absorption peak of Cytaa3. The attenuation is a strong function of
reduced scattering coefficient at both absorption coefficients and varies by more than 25% of
the dynamic range of the attenuation spectrum when the reduced scattering coefficient varies
from 1.0 to 2.0mm−1. In contrast, the differential pathlength is a weak function of reduced
scattering coefficient and varies by less than 5% over the same range.

Fig. 4. First differential of the attenuation spectra with and without Cytc from Fig. 3 (right) and
decomposition into chromophore and scattering components (left).

Figure 4 shows the first differential of the attenuation spectra shown in Fig. 3 and the
chromophore and scattering components that compose the first differential of the attenuation
spectrum. The chromophore components are the product of the differential pathlength,
chromophore concentration and first differential of the specific extinction spectrum and the
scattering component is the product of differential scatter length and first differential of the
scattering coefficient [see Eq. (6)]. The scattering component, which is ≈0.56mOD/nm, is
much smaller than the absorption components mainly because the scattering coefficient is a
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slowly varying function of wavelength but also because the magnitude of the differential
scatterlength is approximately one fourth that of the differential pathlength.
3.2. Phantom studies
The ability to quantify and separate the hemoglobin and Cytc chromophores was examined in
phantoms by desaturating the hemoglobin in the absence or presence of reduced Cytc.
Representative data from the studies is shown in Fig. 5.

Fig. 5. Representative traces of hemoglobin concentration (upper panels) hemoglobin
saturation (middle panels) and Cytc oxidation state (lower panels) of the phantom studies. Left
panels. Initially, the phantom contained 1% intralipid and then 50μmoles/L of oxygenated
hemoglobin was added at time zero followed by desaturation between 2 and 3 minutes. Right
panels: Same as left except 10μmoles/L of reduced Cytc was added prior to desaturation.

The algorithm measures the concentration of reduced Cytc because it has the sharp
spectral feature at 550nm that is amplified by the first differential. The concentration of
reduced Cytc is plotted on a negative scale so that a reduction of Cytc, that is, increased
concentration of reduced Cytc and a decrease concentration of oxidized Cytc results in a
downward deflection.
Initially, the phantom contained only 1% intralipid and the hemoglobin concentration was
zero. At time zero, 50μmoles/L of hemoglobin was added to the oxygenated chamber
resulting in a measured hemoglobin concentration of 48.5 ± 1.0μmoles/L and saturation of
≈94.8 ± 0.3% (mean ± SD, n = 8). Addition of hemoglobin in the absence of Cytc resulted in
a measured oxidation of Cytc to +0.04 ± 0.01μmoles/L (n = 8). Subsequent addition of
10μmoles/L of reduced Cytc resulted in a measured reduction of Cytc to −10.1 ± 0.5μmoles/L
(n = 4). The hemoglobin was then desaturated was passing nitrogen through the tubing
immersed in the phantom resulting in a final concentration of 50.3 ± 2.1μmoles/L and a
saturation of 1.7 ± 0.6% (n = 8). The change in the Cytc signal on desaturation when
10μmoles/L of Cytc was present or absent was −0.00 ± 0.1 (n = 4) and −0.1 ± 0.1μmoles/L (n
= 4) respectively. The data shows that the algorithm can accurately measure the oxidation
state of Cytc in the presence of hemoglobin at any hemoglobin saturation.
The crosstalk between Cytc and oxygenated or deoxygenated hemoglobin was quantified
in greater detail by measuring the Cytc signal when the phantom hemoglobin concentration
was varied in the absence of Cytc under oxygenated or deoxygenated conditions (Fig. 6). As
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Fig. 6. Crosstalk between Cytc and hemoglobin as a function of oxygenated or deoxygenated
hemoglobin concentration. 10 μmoles/L steps of hemoglobin were added to either a saturated
or desaturated phantom contain 1% intralipid and no Cytc. Observed changes in Cytc were
then attributed to crosstalk. Data is expressed as mean ± SD (n = 6).

could be expected, the crosstalk between HbO2 and Cytc was greater than between Hb and
Cyt because the first differential of the HbO2 is greater than that of Hb. The crosstalk from Hb
into Cytc was approximately linear with a value of 0.03 μmoles/L of Cytc per μmoles/L of
Hb. In contrast, the crosstalk of HbO2 into Cytc was nonlinear and reached 1.6μmoles/L
(equivalent to 16% of Cytc assuming a content of 10μmoles/L) at an HbO2 concentration of
100μmoles/L. However, at physiological concentrations of hemoglobin (≈50-60μmoles/L) the
crosstalk from HbO2 and Hb is very similar and amounts to 2-4% of the total Cytc content.
3.3. In vivo studies
The oxidation state of the hemes is independent of oxygen tension at high oxygen tension but
it becomes progressively more reduced when oxygen tension limits oxidative phosphorylation
and become fully reduced when the mitochondria become anoxic [7,33]. Unlike hemoglobin,
the baseline oxidation state is not fully oxidized but depends on energetic status of the
mitochondria [4]. A brief anoxia was performed in six rats weighing 250 ± 60g by switching
the inspired oxygen fraction (FiO2) to 0.00 for 45 seconds and then returning FiO2 to 0.30.
The anoxia is sufficiently long to nearly fully desaturate the brain but sufficiently short to
allow the cerebral hemodynamics and metabolism to return to baseline in 5 minutes. It is
believed that such a short period of anoxia will not result in tissue damage. The baseline
physiological parameters were: mean arterial blood pressure 99 ± 14mmHg, heart rate 460 ±
20 beats/minute, temperature 37.0 ± 0.2°C, arterial pH 7.43 ± 0.03, arterial oxygen tension
136 ± 23mmHg and arterial CO2 tension 38.2 ± 2.2mmHg.
Typical first differential spectra from the rat cortex under normoxic and anoxic conditions
are shown in Fig. 7 along with the fit to the data, the residuals of the fit and the component of
the fit attributed to Cytc. The Cytc component has been offset by 40mOD/nm for reasons of
clarity. The residuals are the difference between the data and the fit and give an indication of
the quality of the fit.
Figure 7 shows the time course of the hemoglobin concentration, mean hemoglobin
saturation (SmcO2) and reduced Cytc concentration during the anoxia and recovery period.
Baseline total hemoglobin was 56.2 ± 5.9µmoles/L, SmcO2 was 67.7 ± 3.8% and Cytc was
2.2 ± 0.3µmoles/L reduced. Anoxia led to a fall in SmcO2 to 7.7 ± 1.9% and a reduction in
Cytc to −7.9 ± 0.9µmoles/L. The anoxia triggered a hyperemia as indicated by the increase in
#169970 - $15.00 USD
(C) 2012 OSA

Received 6 Jun 2012; revised 19 Jul 2012; accepted 21 Jul 2012; published 25 Jul 2012
1 August 2012 / Vol. 3, No. 8 / BIOMEDICAL OPTICS EXPRESS 1943

Fig. 7. Typical first-differential attenuation spectra, fitting model and time chromophore course
during an anoxic challenge. Left panels: fitting residuals and Cytc component of the fit from
the normoxic rat cortex (upper) and during anoxia (lower). The Cytc component has been
offset by −40mOD/nm for reasons of clarity. Time course of the hemoglobin concentration
(upper graph), mean hemoglobin saturation (middle graph) and Cytc during a brief anoxic
insult and recovery. The shaded regions correspond to the period of anoxia. Data is expressed
as mean ± SD (n = 6) and only every 10th error bar is shown for reasons of clarity.

Fig. 8. Relationship between Cytc oxidation and SmcO2 during the onset of anoxia. Data is
expressed as mean ± SD (n = 6). The x error bars are not shown for clarity.

HbT and, on reoxygenation, SmcO2 increased to 87.7 ± 3.8% and Cytc rapidly reoxidized to
baseline followed by a very small but prolonged reduction below baseline. The RMS noise on
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the baseline Cytc signal is ≈0.035µmoles/L with 0.5 second time resolution equivalent to a
0.45% oxidation change in Cytc.
Previous NIR work in the piglet [27] and the rat [34] has shown that the oxidation state of
the CuA center is independent of hemoglobin saturation at normoxia and does not begin to
reduce until there is a substantial decrease in SmcO2. Figure 8 shows the relationship between
Cytc and SmcO2 on the onset of anoxia for the data from Fig. 7 and is comparable with the
piglet data where the CuA was independent of SmcO2 until SmcO2 fell below 50% [27].
Previously, CuA did not reduce until SmcO2 fell below ≈30% in the rat [34] and the difference
could due to the increased crosstalk in the NIRS rat studies, as evidenced by the small
oxidation prior to reduction, or could be a strain difference; we find the baseline SmcO2 is
typically 65% in Wistar rats and 75% in Sprague Dawley rats under the same ventilation
conditions.
4. Discussion
The primary goal of tissue spectroscopy is to accurately quantify the tissue chromophore
concentrations. Accurately separating the chromophore concentrations is an important part of
this goal which becomes critical when one chromophore is at a much lower concentration
than another or has a much weaker extinction spectrum. This problem is compounded when
trying to measure the mitochondrial signals in the rat brain because the cytochromes are both
at a lower concentration and have weaker absorption spectra. The studies presented here show
that Cytc can be successfully separated from hemoglobin and this is in large part due to taking
the first differential of the attenuation spectrum. The first differential provides preferential
sensitivity to the mitochondrial signals over the hemoglobin signals because they have sharper
specific absorption spectrum and, furthermore, the first differential of the chromophore
spectra are highly orthogonal which makes the inversion matrix well-conditioned allowing
their precise separation. The non-linearity between the attenuation and absorption leads to a
distortion of the attenuation spectrum with regard to the absorption spectrum which must be
precisely accounted for by the light-transport model in order in order to prevent crosstalk into
Cytc. For the first differential fitting, the first differential of the attenuation spectrum is still
distorted with respect to the first differential of the absorption spectrum but, in this case, the
distortion is given by the wavelength-dependence of the differential pathlength. We find that
the hemoglobin and Cytc traces are very similar when fitting the first differential of in vivo
data with a simple linear model that assumes both the differential pathlength and differential
scattering are wavelength independent compared to using the full Monte Carlo model. Thus
the main role of the Monte Carlo model is to accurately scale the calculated chromophore
concentrations rather than to correct for the spectral distortions and provide precise
separation.
The first differential of the attenuation spectrum is only weakly dependent on the reduced
scattering coefficient through the differential pathlength and the scattering term. We are not
able to calculate the scattering coefficient from the attenuation spectra and instead have to
assume a value. This may seem to be a weakness of the algorithm but, in terms of separating
the hemoglobin and cytochrome signals, it is in fact a strength because it means that errors in
the estimation of the scattering coefficient do not lead to crosstalk between the hemoglobin
and cytochrome signals. Furthermore, changes in the scattering coefficient during a study will
also not lead to cross talk. Overall, the weak dependence of the parameters on the model of
light transport through the tissue makes the algorithm robust to the inevitable errors in the
model and prevents the model-data mismatches propagating from into chromophore
concentration errors.
Intensity calibration is also relatively simple with the first differential algorithm because
the optical properties of the intensity phantom do not need to be known as long as the absolute
attenuation spectrum is not more than linear with wavelength. The first differential removes
any offset on the attenuation spectrum due to wavelength-independent coupling losses
between the fiber and the tissue and any other wavelength independent effects. Furthermore
the offset used to fit the scattering term automatically corrects for a linear term in the
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attenuation of the reference phantom allowing Teflon, a fluorocarbon with negligible
absorption at visible wavelengths but high scattering coefficient, to be used as the attenuation
reference.
One weakness of the differential algorithm is that it requires attenuation spectra with high
spectral resolution, high signal to noise and negligible fixed-pattern noise. The spectral
resolution and signal to noise can easily be obtained with 0.3m spectrographs and cooled 2dimension CCD detectors. Cooling to 210 Kelvin essentially removes the thermally induced
signal, even for hot pixels, preventing thermal fixed-pattern noise. The integration of charge
over a column of pixels on a 2-dimensional CCD also averages pixel to pixel variations in
quantum efficiency and so minimizes fixed-pattern noise. Sufficient light was obtained from a
filtered 100W tungsten halogen lamp but this could be replaced with a high-power white light
emitting diode (LED) reducing overall system cost and increasing portability.
It was found that crosstalk into Cytc was greater from HbO2 compared to Hb (Fig. 6) as
might be anticipated because HbO2 has a more intense first-differential spectrum. However,
the crosstalk is not linear with HbO2 as might be expected but increases substantially at high
HbO2 concentrations. This may limit the utility of the technique in certain tissues with a very
high hemoglobin content but the crosstalk at the concentrations of hemoglobin found in the
rat brain (50-60μmoles/L) represents only 2-4% of the total Cytc content making it suitable
for brain studies. The crosstalk with HbO2 may be a result of the corpuscular nature of red
blood cells. As is common, the hemoglobin concentration is modeled as homogeneous
background at a concentration of 50-60μmoles/L whereas, in reality, it is packed into red
blood cells at a concentration of 5-6mmoles/L and the red blood cells make up ≈1%V/V. The
crosstalk may be reduced by taking the heterogeneity into account, either analytically at the
level of the spectra as has been attempted before [35], or directly in the Monte Carlo
simulation.
Cytc usually resides in the mitochondria inner membrane space where it transfers
electrons from the bc1 complex to CytOx as part of the electron transport chain. These
electrons are subsequently used to reduce oxygen to water. Cytc does not react directly with
oxygen and, unlike hemoglobin, Cytc is not fully oxidized at high oxygen tension. The
oxidation state of Cytc is independent of oxygen tension at high oxygen tension but Cytc does
become progressively reduced when oxygen tension falls to low levels sufficient to limit
CytOx. Our previous work in piglet brain with the CuA center of CytOx predicts, and is
confirmed here, that the oxidation state of Cytc will be independent of oxygen tension at
normoxia and only become reduced under hypoxic conditions [27,36]. This makes Cytc a
sensitive indicator of hypoxia at the mitochondrial level making it useful for functional
activation studies, where there is considerable controversy as to mitochondrial oxygenation,
and to ischemic studies where hypoxia at the mitochondrial level is the primary cause of the
loss in tissue viability.
Another major role of Cytc it to trigger programmed cell death when it is released from
the mitochondria into the cytosol (see [37] for a review). Our previous work in cell culture
shows that Cytc becomes reduced when released into cytosol and this reduction allows Cytc
to be used as a sensitive and quantitative measure of Cytc release [38]. Implementation of this
algorithm and measurement of Cytc oxidation states should be unique physiological
information in the study of ischemia and seizures, both of which can lead to the loss of tissue
viability.
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